Enac variants associated with genetic susceptibility for COVID-19

The lipid profiles of patients with COVID-19 are quite variable. A likely explanation is that the genetics and epigenetics of dyslipidemia and other pathologic states may differ among patients with COVID-19. In the context of the growing need to understand the pathogenic mechanisms of this aggressive RNA virus and its relation to dyslipidemia and other cardiovascular traits, we aimed to study a comprehensive panel of specific genes involved in cardio-pulmonary, metabolic, and vascular disorders.